Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 21, 2013; 19(23): 3649-3657
Published online Jun 21, 2013. doi: 10.3748/wjg.v19.i23.3649
Figure 1
Figure 1 Kaplan-Meier curve shows overall survival rates of different treatment modalities in hepatocellular carcinoma patients who survived between 5 years and 10 years. Different treatment models showed statistically significant differences in the survival period: surgery alone > surgery-transcatheter arterial chemoembolization (TACE) > TACE-radiofrequency ablation (RFA) > TACE alone > surgery-TACE-RFA.